Your browser doesn't support javascript.
loading
Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia.
Yoshida, Chikashi; Komeno, Takuya; Hori, Mitsuo; Kimura, Tomofumi; Fujii, Masami; Okoshi, Yasushi; Suzukawa, Kazumi; Chiba, Shigeru; Hasegawa, Yuichi; Mukai, Harumi Yamamoto; Ito, Takayoshi; Shimizu, Seiichi; Kamoshita, Masaharu; Kudo, Daisuke; Shinagawa, Atsushi; Chikatsu, Norio; Monma, Yuriko; Watanabe, Norimichi; Kojima, Hiroshi.
Afiliação
  • Yoshida C; Department of Hematology, National Hospital Organization Mito Medical Center, Higashiibarakigun, Japan.
  • Komeno T; Department of Hematology, National Hospital Organization Mito Medical Center, Higashiibarakigun, Japan.
  • Hori M; Department of Hematology, Ibaraki Prefectural Central Hospital, Kasama, Japan.
  • Kimura T; Division of Hematology, Suifu Hospital, Mito, Japan.
  • Fujii M; Division of Hematology, Suifu Hospital, Mito, Japan.
  • Okoshi Y; Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
  • Suzukawa K; Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
  • Chiba S; Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
  • Hasegawa Y; Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
  • Mukai HY; Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
  • Ito T; Department of Hematology, Toride Kyodo General Hospital, Toride, Japan.
  • Shimizu S; Department of Hematology, Tsuchiura Kyodo General Hospital, Tsuchiura, Japan.
  • Kamoshita M; Department of Hematology, Tsuchiura Kyodo General Hospital, Tsuchiura, Japan.
  • Kudo D; Department of Hematology, Hitachi General Hospital, Hitachi, Japan.
  • Shinagawa A; Department of Hematology, Hitachi General Hospital, Hitachi, Japan.
  • Chikatsu N; Department of Hematology, Hitachi General Hospital, Hitachi, Japan.
  • Monma Y; Department of Hematology, Hitachi General Hospital, Hitachi, Japan.
  • Watanabe N; Watanabe Naika Clinic, Hitachinaka, Japan.
  • Kojima H; Department of Clinical Oncology, Ibaraki Prefectural Central Hospital, Kasama, Ibaraki, 309-1793, Japan. h-kojima@chubyoin.pref.ibaraki.jp.
Int J Hematol ; 93(5): 618-623, 2011 May.
Article em En | MEDLINE | ID: mdl-21523339
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Pirimidinas / Proteínas Tirosina Quinases / Leucemia Mieloide de Fase Crônica / Proteínas de Fusão bcr-abl / Inibidores de Proteínas Quinases Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2011 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Pirimidinas / Proteínas Tirosina Quinases / Leucemia Mieloide de Fase Crônica / Proteínas de Fusão bcr-abl / Inibidores de Proteínas Quinases Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2011 Tipo de documento: Article